Surgical removal of atrial septal defect occlusion device and mitral valve replacement in a 39-year-old female patient with infective endocarditis
- Authors: Zotov AS1, Borisov DV1, Klypa TV1, Vachev SA1
-
Affiliations:
- Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency
- Issue: Vol 99, No 1 (2018)
- Pages: 140-143
- Section: Clinical observations
- URL: https://journal-vniispk.ru/kazanmedj/article/view/7822
- DOI: https://doi.org/10.17816/KMJ2018-140
- ID: 7822
Cite item
Full Text
Abstract
Atrial septal defects represent the second most frequent congenital heart disease after ventricular septal defects. Transcatheter closure of an atrial septal defect is usually performed following strict indications on patients with significant left-to-right shunt. Infective endocarditis after transcatheter implantation of atrial septal defect occluder is an extremely rare complication. We report a case of infective endocarditis of the mitral valve (with severe mitral valve insufficiency) in a 39-year-old female patient 13 years after transcatheter closure of an atrial septal defect. Complex prophylactic antibiotic coverage was performed prior to surgical intervention. Surgical removal of atrial septal defect occluder, mitral valve replacement, atrial septal defect closure and left atrial appendage resection were performed. Postoperative course was uneventful.
Full Text
##article.viewOnOriginalSite##About the authors
A S Zotov
Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency
Author for correspondence.
Email: dan-cer@inbox.ru
Moscow, Russia
D V Borisov
Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency
Email: dan-cer@inbox.ru
Moscow, Russia
T V Klypa
Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency
Email: dan-cer@inbox.ru
Moscow, Russia
S A Vachev
Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency
Email: dan-cer@inbox.ru
Moscow, Russia
References
- Van der Linde D., Konings E.E., Slager M.A et al. Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis. J. Am. Coll. Cardiol. 2011; 58: 2241-2247. doi: 10.1016/j.jacc.2011.08.025.
- Warnes C.A., Williams R.G., Bashore T.M. et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2008; 52: e143-e263. doi: 10.1016/j.jacc.2008.10.001.
- Murray C.J., Vos T., Lozano R. et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2197-2223. doi: 10.1016/S0140-6736(12)61689-4.
- Duval X., Delahaye F., Alla F. et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: Three successive population-based surveys. J. Am. Coll. Cardiol. 2012; 59: 1968-1976. doi: 10.1016/j.jacc.2012.02.029.
- Correa de Sa D.D., Tleyjeh I.M., Anavekar N.S. et al. Epidemiological trends of infective endocarditis: A population-based study in Olmsted County, Minnesota. Mayo Clin. Proc. 2010; 85: 422-426. doi: 10.4065/mcp.2009.0585.
- Federspiel J.J., Stearns S.C., Peppercorn A.F. et al. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch. Intern. Med. 2012; 172: 363-365. doi: 10.1001/archinternmed.2011.1027.
- Thuny F., Grisoli D., Cautela J. et al. Infective endocarditis: Prevention, diagnosis, and management. Can. J. Cardiol. 2014; 30: 1046-1057. doi: 10.1016/j.cjca.2014.03.042.
- Marelli A.J., Mackie A.S., Ionescu-Ittu R. et al. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007; 115: 163-172. doi: 10.1161/CIRCULATIONAHA.106.627224.
- Khairy P., Ionescu-Ittu R., Mackie A.S., et al. Changing mortality in congenital heart disease. J. Am. Coll. Cardiol. 2010; 56: 1149-1157. doi: 10.1016/j.jacc.2010.03.085.
- Habib G., Hoen B., Tornos P. et al. Guidelines ESCCfP. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Eur. Heart J. 2009; 30: 2369-2413. doi: 10.1093/eurheartj/ehp285.
- Amedro P., Soulatges C., Fraisse A. Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature. Catheter Cardiovasc. Interv. 2017; 89 (2): 324-334. doi: 10.1002/ccd.26784.
- Chessa M., Carminati M., Butera G. et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J. Am. Coll. Cardiol. 2002; 39: 1061-1065. doi: 10.1016/S0735-1097(02)01711-4.
- Thibodeau-Jarry N., Ibrahim R., Ducharme A., Sia Y.T. Late infection of an atrial septal defect closure device: A possible complication. Can. J. Cardiol. 2015; 31: 1204, e9-e11. doi: 10.1016/j.cjca.2015.01.043.
- Bialkowski J., Pawlak S., Banaszak P. Incomplete endothelialisation of an Amplatzer Septal Occluder device followed by meningitis and late acute bacterial endocarditis. Cardiol. Young. 2016; 26: 808-810. doi: 10.1017/S1047951115002383.
Supplementary files
